AlmawiW. Y.; AssiJ. W.; ChudzikD. M.; JaoudeM. M. A.; RiederM. J.Inhibition of cytokine production and cytokine-stimulated T-cell activation by FK506 (Ta-crolimus)1.Cell Transplant.10: 615623; 2001.
2.
AlmawiW. Y.; TamimH.Posttranscriptional mechanisms of glucocorticoid antiproliferative effects: Glucocorticoids inhibit IL-6-induced proliferation of B9 hybridoma cells.Cell Transplant.10: 161164; 2001.
3.
ArmstrongR. J. E.; SvendsenC. N.Neural stem cells: From cell biology to cell replacement.Cell Transplant.9: 139152; 2000.
4.
ArmstrongR. J. E.; WattsC.; SvendsenC. N.; DunnettS. B.; RosserA. E.Survival, neuronal differentiation, and fiber outgrowth of propagated human neural precursor grafts in an animal model of Huntington's disease.Cell Transplant.9: 5564; 2000.
5.
BankiewiczK. S.; BringasJ.; PivirottoP.; KutzscherE.; NagyD.; EmborgM. E.Technique for bilateral intracranial implantation of cells in monkeys using an auto-mated delivery system.Cell Transplant.9: 595607; 2000.
6.
BarkerR. A.; KendallA. L.; WidnerH.; and the Neural Tissue Xenografting Project. Neural tissue xenotransplantation: What is needed prior to clinical trials in Parkinson's disease?Cell Transplant.9: 235246; 2000.
7.
BaustJ. M.; VogelM. J.; Van BuskirkR.; BaustJ. G.A molecular basis of cryopreservation failure and its modulation to improve cell survival.Cell Transplant.10: 561571; 2001.
8.
BenazzouzA.; PiallatB.; NiZ. G.; KoudsieA.; PollakP.; BenabidA. L.Implication of the subthalamic nucleus in the pathophysiology and pathogenesis of Parkinson's disease.Cell Transplant.9: 215221; 2000.
9.
BerneyT.; MolanoR. D.; PileggiA.; CattanP.; VizzardelliC.; RicordiC.; InverardiL.Absence of CSF-1-dependent macrophages does not improve function of transplanted islets of Langerhans.Cell Transplant.10: 633637; 2001.
10.
BlakemoreW. F.; FranklinJ. M.Transplantation options for therapeutic central nervous system remyelination.Cell Transplant.9: 289294; 2000.
11.
BlitsB.; DijkhuizenP. A.; HermensW. T. J. M. C.; van EsseveldtL. K. E.; BoerG. J.; VerhaagenJ.The use of adenoviral vectors and ex vivo transduced neurotransplants: Towards promotion of neuroregeneration.Cell Transplant.9: 169178; 2000.
12.
BoerG. J.The Network of European CNS Transplantation and Restoration (NECTAR): An introduction on the occasion of its tenth meeting.Cell Transplant.9: 133138; 2000.
13.
BorlonganC. V.; SuT.; WangY.Delta opioid peptide augments functional effects and intrastriatal graft survival of rat fetal ventral mesencephalic cells.Cell Transplant.10: 5358; 2001.
14.
BradyJ. L.; YamashitaK.; LewA. M.Enhanced survival of grafts genetically endowed with the ability to block CD2 and B7.Cell Transplant.10: 175181; 2001.
15.
BrevigT.; MeyerM.; KristensenT.; ZimmerJ.Neural xenotransplantation: Pretreatment of porcine embryonic nigral tissue with anti-gal antibodies and complement is not toxic for the dopaminergic neurons.Cell Transplant.10: 2530; 2001.
16.
BrierleyC. M. H.; CrangA. J.; IwashitaY.; GilsonJ. M.; ScoldingN. J.; CompstonD. A. S.; BlakemoreW. F.Remyelination of demyelinated CNS axons by transplanted human Schwann cells: The deleterious effect of contaminating fibroblasts.Cell Transplant.10: 305315; 2001.
17.
BrundinP.; KarlssonJ.; EmgårdM.; SchierleG. S. K.; HanssonO.; PetersénÅ.; CastilhoR. F.Improving the survival of grafted changes after terminal striatal 6-OHDA lesion and transplantation of dopaminergic embryonic micrografts.Cell Transplant.9: 179195; 2000.
18.
CunninghamJ.; OiwaY.; NagyD.; PodsakoffG.; ColosiP.; BankiewiczK. S.Distribution of AAA-TK following intracranial convection-enhanced delivery into rats.Cell Transplant.9: 585594; 2000.
19.
DanielsenE. H.; CummingP.; AndersenF.; BenderD.; BrevigT.; FalborgL.; GeeA.; GillingsN. M.; HansenS. B.; HermansenF.; JohansenJ.; JohansenT. E.; Dahl-JørgensenA.; JørgensenH. A.; MeyerM.; MunkO.; PedersenE. B.; PoulsenP. H.; RodellA. B.; SakohM.; SimonsenC. Z.; SmithD. F.; SøorensenJ. C.; Øster-gardL.; ZimmerJ.; GjeddeA.; MøllerA.The DaNeX study of embryonic mesencephalic, dopaminergic tissue grafted to a minipig model of Parkinson's disease: Preliminary findings of effect of MPTP poisoning on striatal dopaminergic markers.Cell Transplant.9: 247259; 2000.
20.
DateI.; ShingoT.; YoshidaH.; FujiwaraK.; KobayashiK.; OhmotoT.Grafting of encapsulated dopamine-secreting cells in Parkinson's disease: Long-term primate study.Cell Transplant.9: 705709; 2000.
21.
DateI.; ShingoT.; YoshidaH.; FujiwaraK.; KobayashiK.; TakeuchiA.; OhmotoT.Grafting of encapsulated genetically modified cells secreting GDNF into the striatum of parkinsonian model rats.Cell Transplant.10: 397401; 2001.
22.
EatonM. J.; MartinezM.; KarmallyS.; LopezT.; SagenJ.Initial characterization of the transplant of immortalized chromaffin cells for the attenuation of chronic neuropathic pain.Cell Transplant.9: 637656; 2000.
23.
EmerichD. F.; SalzbergH. C.Update on immunoisolation cell therapy for CNS diseases.Cell Transplant.10: 324; 2001.
24.
EspejoM.; CutillasB.; ArenasE.; AmbrosioS.Increased survival of dopaminergic neurons in striatal grafts of fetal ventral mesencephalic cells exposed to neurotrophin-3 or glial cell line-derived neurotrophic factor.Cell Transplant.9: 4553; 2000.
GrayJ. A.; GrigoryanD. V.; PatelS.; SindenJ. D.; HodgesH.Conditionally immortalized, multipotential and multifunctional neural stem cell lines as an approach to clinical transplantation.Cell Transplant.9: 153168; 2000.
28.
HamanoK.; LiT.; KobayashiS.; MatsuzakiM.; EsatoK.Angiogenesis induced by the implantation of self-bone marrow cells: A new material for therapeutic angiogenesis.Cell Transplant.9: 439443; 2000.
29.
HaqueN. S. K.; IsacsonO.Neurotrophic factors NGF and FGF-2 alter levels of huntingtin (IT15) in striatal neuronal cell culture.Cell Transplant.9: 623627; 2000.
30.
HaraK.; UchidaK.; FukunagaA.; KuroshimaY.; YamadaM.; KawaseT.Neurite growth capability of rat fetal neuronal cells against matured CNS myelin in vitro.Cell Transplant.9: 717724; 2000.
31.
HowellL. L.; ByrdL. D.; McDonoughA. M.; IuvoneP. M.; BakayR. A. E.Behavioral evaluation of hemiparkinsonian MPTP monkeys following dopamine pharmacological manipulation and adrenal co-graft transplantation.Cell Transplant.9: 609622; 2000.
32.
HurelbrinkC. B.; ArmstrongR. J. E.; BakerR. A.; DunnettS. B.; RosserA. E.Hibernated human fetal striatal tissue: Successful transplantation in a rat model of Huntington's disease.Cell Transplant.9: 743749; 2000.
33.
KoopmansJ.; HogenEschI.; CoprayS.; MiddelB.; van DijkH.; GoK.-G.; StaalM.Cryopreservation of porcine fetal ventral mesencephalic tissue for intrastriatal transplantation in Parkinson's disease.Cell Transplant.10: 573581; 2001.
34.
KosugaM.; TakahashiS.; SasakiK.; EnosawaS.; LiK.; OkuyamaS.; FujinoM.; SuzukiS.; YamadaM.; MatsuoN.; SakuragawaN.; OkuyamaT.Phenotype correction in murine mucopolysaccharidosis type VII by transplantation of human amniotic epithelial cells after adenovirus-mediated gene transfer.Cell Transplant.9: 687692; 2000.
35.
KosugaM.; TakahashiS.; TanabeA.; FujinoM.; LiX.-K.; SuzukiS.; YamadaM.; KakishitaK.; OnoF.; SakuragawaN.; OkuyamaS.Widespread distribution of adenovirus-transduced monkey amniotic epithelial cells after local intracerebral injection: Implication for cell-me-diated therapy for lysosome storage disorders.Cell Transplant.10: 435439; 2001.
36.
LarssonL. C.; AndersonP.; WidnerH.; KorsgrenO.Enhanced survival of porcine neural xenografts in mice lacking CD1d1, but no effect of NK1.1 depletion.Cell Transplant.10: 295304; 2001.
37.
LarssonL. C.; CzechK. A.; BrundinP.; WidnerH.Intrastriatal ventral mesencephalic xenografts of porcine tissue in rats: Immune responses and functional effects.Cell Transplant.9: 261272; 2000.
38.
LiK.; YangM.; LamA. C.; YauF. W.; YuenP. M. P.Effects of Flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors.Cell Transplant.9: 125131; 2000.
39.
LiY.; ChenJ.; ChoppM.Adult bone marrow transplantation after stroke in adult rats.Cell Transplant.10: 3140; 2001.
40.
McKenzieA. W.; GeorgiouH. M.; ZhanY.; BradyJ. L.; LewA M.Protection of xenografts by a combination of immunoisolation and a single dose of anti-CD4 antibody.Cell Transplant.10: 183193; 2001.
41.
MizumotoH.; MizumotoK.; WhiteleyS. J. O.; ShatosM.; KlassenH.; YoungM. J.Transplantation of human neural progenitor cells to the vitreous cavity of the Royal College of Surgeons rat.Cell Transplant.10: 223233; 2001.
42.
Mundt-PetersenU.; KarlssonJ.; SchierleG. S. K.; BrundinP.Pretreatment with MK-801 or the lazaroid U-83836E does not enhance striatal graft survival.Cell Transplant.9: 7378; 2000.
43.
NakamuraK.; AhmedM.; BarrE.; LeidenJ. M.; KangU. J.The localization and functional contribution of striatal aromatic L-amino acid decarboxylase to L-3,4-dihydroxphenylalanine decarboxylation in rodent Parkinsonian models.Cell Transplant.9: 567576; 2000.
44.
PetersénÅ.; HanssonO.; EmgårdM.; BrundinP.Grafting of nigral tissue hibernated with tirilazad mesylate and glial cell line-derived neurotrophic factor.Cell Transplant.9: 577584; 2000.
45.
PlantG. W.; HarveyA. R.A new type of biocompatible bridging structure supports axon regrowth after implantation into the lesioned optic tract.Cell Transplant.9: 759772; 2000.
46.
Rivas-ArancibiaS.; WillingA. E.; ZigovaT.; RodriguezA. I.; CahillD. W.; SanbergP. R.The effects of taurine on hNT neurons transplanted in adult rat stratum.Cell Transplant.9: 751758; 2000.
47.
RödterA.; WinklerC.; SamiiM.; NikkhahG.Complex sensorimotor behavioral changes after terminal striatal 6-OHDA lesion and transplantation of dopaminergic embryonic micrografts.Cell Transplant.9: 197214; 2000.
48.
SanbergP. R.; BrundinP.Cell transplantation and neuroscience.Cell Transplant.8: 36; 1999.
SchraermeyerU.; ThumannG.; LutherT.; KociokN.; ArnholdS.; KruttwigK.; AndressenC.; AddicksK.; Bartz-SchmidtK. U.Subretinally transplanted embryonic stem cells rescue photoreceptor cells from degeneration in the RCS rats.Cell Transplant.10: 673680; 2001.
51.
TeradaS.; MatsuuraK.; EnosawaS.; MikiM.; HoshikaA.; SuzukiS.; SakuragawaN.Inducing proliferation of human amniotic epithelial (HAE) cells for cell therapy.Cell Transplant.9: 701704; 2000.
52.
ThorsenF.; ReadT.; Lund-JohansenM.; TysnesB. B.; BjerkvigR.Alginate-encapsulated producer cells: A potential new approach for the treatment of malignant brain tumors.Cell Transplant.9: 773783; 2000.
53.
TkaczukJ.; BesJ. C.; DuplanH.; SallerinB.; TafaniM.; CharletJ. P.; AbbalM.; LazorthesY.; OhayonE.Intrathecal grafting of unencapsulated adrenal medullary tissue can bring CD4 T lymphocytes into CSF: A potentially deleterious event for the graft.Cell Transplant.9: 7991; 2000.
54.
TuszynskiM. H.Proceedings of the meeting of the American Society for Neural Transplantation and Repair (ASNTR), 1999.Cell Transplant.9: 565566; 2000.
VerdugoM. E.; AllingJ.; LazarE. S.; del CerroM.; RayJ.; AguirreG.Posterior segment approach for sub-retinal transplantation or injection in the canine model.Cell Transplant.10: 317327; 2001.
57.
VizzardelliC.; PotterE. D.; BerneyT.; PileggiA.; InverardiL.; RicordiC.; SagenJ.Automated method for isolation of adrenal medullary chromaffin cells from neonatal porcine glands.Cell Transplant.10: 689696; 2001.
58.
WattsC.; BrastedP. J.; DunnettS. B.The morphology, integration, and functional efficacy of striatal grafts differ between cell suspensions and tissue pieces.Cell Transplant.9: 395407; 2000.
59.
WattsC.; DunnettS. B.Towards a protocol for the preparation and delivery of striatal tissue for clinical trials of transplantation in Huntington's disease.Cell Transplant.9: 223234; 2000.
60.
WattsC.; McNamaraI. R.; DunnettS. B.Volume and differentiation of striatal grafts in rats: Relationship to the number of cells implanted.Cell Transplant.9: 6572; 2000.
61.
WeisC.; KaufmannW. A.; HumpelC.Lipid-mediated in vivo gene transfer replaces the loss of choline acetyl-transferase activity after unilateral fimbria-fornix aspiration.Cell Transplant.10: 681688; 2001.
62.
WenningG. K.; TisonF.; ScherflerC.; PuschbanZ.; WaldnerR.; GranataR.; GhorayebI.; PoeweW.Towards neurotransplantation in multiple system atrophy: Clinical rationale, pathophysiological basis, and preliminary experimental evidence.Cell Transplant.9: 279288; 2000.
63.
YurekD. M.; Fletcher-TurnerA.; MooreJ.; ChaiL.; MahanthappaN.Co-grafts of fetal ventral mesencephalon and fibroblasts expressing sonic hedgehog: Effect on survival and function of dopamine grafts.Cell Transplant.10: 665671; 2001.
64.
ZamanV.; TurnerD. A.; ShettyA. K.Prolonged post-lesion transplantation delay adversely influences survival of both homotopic and heterotopic fetal hippocampal cell grafts in kainate-lesioned CA3 region of adult hippocam-pus.Cell Transplant.10: 4152; 2001.
65.
ZurnA. D.; HenryH.; SchluepM.; AubertV.; WinkelL.; EilersB.; BachmannC.; AebischerP.Evaluation of an intrathecal immune response in amyotrophic lateral sclerosis patients implanted with encapsulated genetically engineered xenogeneic cells.Cell Transplant.9: 471484; 2000.